The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data
Abstract
Background: Concerns have been expressed about possible adverse effects of the use of antidepressant medication during pregnancy, including risk for neonatal pathology and the presence of congenital malformations. Method: Data from the Swedish Medical Birth Register (MBR) from 1 July 1995 up to 2007 were used to identify women who reported the use of antidepressants in early pregnancy or were prescribed antidepressants during pregnancy by antenatal care: a total of 14 821 women with 15 017 infants. Maternal characteristics, maternal delivery diagnoses, infant neonatal diagnoses and the presence of congenital malformations were compared with all other women who gave birth, using the Mantel–Haenszel technique and with adjustments for certain characteristics. Results: There was an association between antidepressant treatment and pre-existing diabetes and chronic hypertension but also with many pregnancy complications. Rates of induced delivery and caesarean section were increased. The preterm birth rate was increased but not that of intrauterine growth retardation. Neonatal complications were common, notably after tricyclic antidepressant (TCA) use. An increased risk of persistent pulmonary hypertension of the newborn (PPHN) was verified. The congenital malformation rate was increased after TCAs. An association between use of paroxetine and congenital heart defects was verified and a similar effect on hypospadias was seen. Conclusions: Women using antidepressants during pregnancy and their newborns have increased pathology. It is not clear how much of this is due to drug use or underlying pathology. Use of TCAs was found to carry a higher risk than other antidepressants and paroxetine seems to be associated with a specific teratogenic property.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
Chambers, C. D., Hernandez-Diaz, S., Van Marter, L. J., Werler, M. M., Louik, C., Jones, K. L., & Mitchell, A. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052744 · Cited by 880
Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.898 · Cited by 551
Antepartum Depressive Symptomatology Is Associated With Adverse Obstetric and Neonatal Outcomes
Chung, T. K. H., Lau, T. K., Yip, A. S. K., Chiu, H. F. K., & Lee, D. T. S. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200109000-00017 · Cited by 501
First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
Louik, C., Lin, A. E., Werler, M. M., Hernández-Díaz, S., & Mitchell, A. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067407 · Cited by 500
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
Alwan, S., Reefhuis, J., Rasmussen, S. A., Olney, R. S., & Friedman, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066584 · Cited by 495 · cited 2×
“…studies, tentative associations between maternal use of SSRIs and specific malformations (anencephaly, craniosynostosis and omphalocele) were suggested (Alwan et al. 2007), observations that were not confirmed in a further study (Louik et al. 2007), where an association with clubfoot was seen.”
ResultMajor Depression and Antidepressant Treatment: Impact on Pregnancy and Neonatal Outcomes
Wisner, K. L., Sit, D. K. Y., Hanusa, B. H., Moses-Kolko, E. L., Bogen, D. L., Hunker, D. F., Perel, J. M., Jones-Ivy, S., Bodnar, L. M., & Singer, L. T. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08081170 · Cited by 400
Outcomes of Prenatal Antidepressant Exposure
Simon, G. E., Cunningham, M. L., & Davis, R. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2055 · Cited by 386
Sanz, E. J., De-las-Cuevas, C., Kiuru, A., Bate, A., & Edwards, R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17865-9 · Cited by 382
Orr, S. T. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf131 · Cited by 357
Dayan, J., Creveuil, C., Marks, M. N., Conroy, S., Herlicoviez, M., Dreyfus, M., & Tordjman, S. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000244025.20549.bd · Cited by 356
Levinson-Castiel, R., Merlob, P., Linder, N., Sirota, L., & Klinger, G. (2006) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.160.2.173 · Cited by 329
Role of Anxiety and Depression in the Onset of Spontaneous Preterm Labor
Dayan, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.4.293 · Cited by 322
Neonate Characteristics After Maternal Use of Antidepressants in Late Pregnancy
Källén, B. (2004) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.158.4.312 · Cited by 300
Self-citationPedersen, L. H., Henriksen, T. B., Vestergaard, M., Olsen, J., & Bech, B. H. (2009) · BMJ · doi:10.1136/bmj.b3569 · Cited by 297
Delivery outcome after the use of antidepressants in early pregnancy
Ericson, A., Källén, B., & Wiholm, B.-E. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050664 · Cited by 284
Self-citationBérard, A., Ramos, É., Rey, É., Blais, L., St.‐André, M., & Oraichi, D. (2007) · Birth Defects Research Part B: Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20099 · Cited by 275
Källén, B. A. J., & Otterblad Olausson, P. (2007) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20327 · Cited by 270
Self-citationPerinatal Outcome Following Third Trimester Exposure to Paroxetine
Costei, A. M., Kozer, E., Ho, T., Ito, S., & Koren, G. (2002) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.156.11.1129 · Cited by 270
Suri, R., Altshuler, L., Hellemann, G., Burt, V. K., Aquino, A., & Mintz, J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06071172 · Cited by 247
Einarson, T. R., & Einarson, A. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1084 · Cited by 230
Bar-Oz, B., Einarson, T., Einarson, A., Boskovic, R., O'Brien, L., Malm, H., Bérard, A., & Koren, G. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.05.003 · Cited by 226
Risks Associated With Selective Serotonin Reuptake Inhibitors in Pregnancy
Malm, H., Klaukka, T., & Neuvonen, P. J. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000187302.61812.53 · Cited by 211
Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study
Diav‐Citrin, O., Shechtman, S., Weinbaum, D., Wajnberg, R., Avgil, M., Di Gianantonio, E., Clementi, M., Weber‐Schoendorfer, C., Schaefer, C., & Ornoy, A. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03261.x · Cited by 207
Li, D., Liu, L., & Odouli, R. (2008) · Human Reproduction · doi:10.1093/humrep/den342 · Cited by 207
Källén, B., & Olausson, P. O. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1570 · Cited by 205
Self-citationDavis, R. L., Rubanowice, D., McPhillips, H., Raebel, M. A., Andrade, S. E., Smith, D., Yood, M. U., & Platt, R. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1462 · Cited by 203
Maternal drug use in early pregnancy and infant cardiovascular defect
KALLEN, B. (2003) · Reproductive Toxicology · doi:10.1016/s0890-6238(03)00012-1 · Cited by 202
McElhatton, P. R., Garbis, H. M., Eléfant, E., Vial, T., Bellemin, B., Mastroiacovo, P., Arnon, J., Rodríguez-Pinilla, E., Schaefer, C., Pexieder, T., et al. (1996) · Reproductive Toxicology · doi:10.1016/0890-6238(96)00057-3 · Cited by 202
Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn
Andrade, S. E., McPhillips, H., Loren, D., Raebel, M. A., Lane, K., Livingston, J., Boudreau, D. M., Smith, D. H., Davis, R. L., Willy, M. E., et al. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1710 · Cited by 195
Oberlander, T. F., Warburton, W., Misri, S., Riggs, W., Aghajanian, J., & Hertzman, C. (2008) · Birth Defects Research Part B: Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20144 · Cited by 187
Maternal Use of Selective Serotonin Reuptake Inhibitors and Risk of Congenital Malformations
Wogelius, P., Nørgaard, M., Gislum, M., Pedersen, L., Munk, E., Mortensen, P. B., Lipworth, L., & Sørensen, H. T. (2006) · Epidemiology · doi:10.1097/01.ede.0000239581.76793.ae · Cited by 185
Paroxetine in the first trimester and the prevalence of congenital malformations
Cole, J. A., Ephross, S. A., Cosmatos, I. S., & Walker, A. M. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1463 · Cited by 162
Congenital Heart Disease Associated With Selective Serotonin Reuptake Inhibitor Use During Pregnancy
Wichman, C. L., Moore, K. M., Lang, T. R., Sauver, J. L. S., Heise, R. H., & Watson, W. J. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.1.23 · Cited by 157
Selective Serotonin Reuptake Inhibitor Exposure In Utero and Pregnancy Outcomes
Lund, N., Pedersen, L. H., & Henriksen, T. B. (2009) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.164 · Cited by 153
Antidepressant drugs during pregnancy and infant congenital heart defect
Källén, B. A. J., & Olausson, P. O. (2006) · Reproductive Toxicology · doi:10.1016/j.reprotox.2005.11.006 · Cited by 149
Self-citationHallberg, P., & Sjöblom, V. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000150228.61501.e4 · Cited by 134
Oberlander, T. F., Warburton, W. P., Misri, S. K., Aghajanian, J., & Hertzman, C. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.037101 · Cited by 134
Neonatal paroxetine withdrawal syndrome
Stiskal, J. A., Kulin, N., Koren, G., Ho, T., & Ito, S. (2001) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.84.2.f134 · Cited by 110
Kallen, B. (1995) · European Journal of Epidemiology · doi:10.1007/bf01719316 · Cited by 110
Selective Serotonin Reuptake Inhibitor Use and Risk of Gestational Hypertension
Toh, S., Mitchell, A. A., Louik, C., Werler, M. M., Chambers, C., & Hernández–Díaz, S. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08060817 · Cited by 105
Methodological issues in the epidemiological study of the teratogenicity of drugs
Källén, B. A. J. (2005) · Congenital Anomalies · doi:10.1111/j.1741-4520.2005.00062.x · Cited by 56
Self-citationAntenatal Use of Selective Serotonin-Reuptake Inhibitors and QT Interval Prolongation in Newborns
Dubnov‐Raz, G., Juurlink, D. N., Fogelman, R., Merlob, P., Ito, S., Koren, G., & Finkelstein, Y. (2008) · PEDIATRICS · doi:10.1542/peds.2008-0658 · Cited by 55
NTP‐CERHR Expert Panel Report on the reproductive and developmental toxicity of fluoxetine
Hines, R. N., Adams, J., Louis, G. M. B., Faber, W. D., Holson, J. F., Jacobson, S. W., Keszler, M., McMartin, K. E., Segraves, R. T., Singer, L. T., et al. (2004) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20014 · Cited by 33
Potts, A. L., Young, K., Carter, B. S., & Shenai, J. P. (2007) · Journal of Perinatology · doi:10.1038/sj.jp.7211640 · Cited by 32
The safety of antidepressant drugs during pregnancy
Källén, B. A. J. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.4.357 · Cited by 30
Self-citation
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“questioned [1108,1113-1117].”
Rai, D., Lee, B. K., Dalman, C., Golding, J., Lewis, G., & Magnusson, C. (2013) · BMJ · doi:10.1136/bmj.f2059 · Cited by 365
Pregnant women with posttraumatic stress disorder and risk of preterm birth
Yonkers, K. A., Smith, M. V., Forray, A., Epperson, C. N., Costello, D., Lin, H., & Belanger, K. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.558 · Cited by 331
Aetiology of hypospadias: a systematic review of genes and environment
van der Zanden, L. F. M., van Rooij, I. A. L. M., Feitz, W. F. J., Franke, B., Knoers, N. V. A. M., & Roeleveld, N. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms002 · Cited by 292
Metadata
- Authors
- Reis, M., & Källén, B.
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2010-01-05
- Volume
- 40
- Issue
- 10
- Pages
- 1723-1733
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2168495021
- Cited by
- 340
- References
- 45
- FWCI
- 36.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.